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Back to basics: the miracle and tragedy of measles vaccine 
As we herald progress towards the Millennium Develop-
ment Goals and strive to meet them, we have an 
approaching public health target that is sometimes 
forgotten. The global community has resolved to reduce 
measles deaths by 95% by 2015, and ﬁ ve of the six WHO 
regions plan to eliminate measles within this decade.1 
The current outbreak of measles in Swansea, UK, is 
tragic in many ways, with hundreds of ill children, health 
staﬀ  stretched and working overtime to care for patients 
and trace contacts, the need for emergency vaccination 
clinics, and the spectre of death from measles.
The Swansea outbreak, like all measles outbreaks in 
Europe during the past 3 years including in other parts 
of the UK, France, the Ukraine, Spain, Italy, Romania, 
Bulgaria, Germany, and Switzerland, was inevitable due 
to large numbers of people who were unimmunised. 
These costly outbreaks were completely preventable.
The measles vaccine—one of the oldest and most 
eﬀ ective in the vaccine arsenal—was introduced 
50 years ago in the USA and 45 years ago in the UK. 
Since then measles has been eliminated from the 
Americas; the only cases in that region today are related 
to importation, many from Europe.2 In fact, Europe is 
lagging behind much more densely populated, poorer 
areas of the world in the battle against measles.
In the WHO European Region there have been more 
than 90 000 cases of measles in the past 3 years alone, 
many of them in the high-income countries of western 
Europe.3 Meanwhile, Cambodia has celebrated more 
than a year without a single case of measles and the 
Western Paciﬁ c Region is well on its way to eliminating 
the virus.
The measles vaccine is responsible for dramatic reduc-
tions in child mortality.4 23% of child deaths prevented 
between 1990 and 2008 were due to the measles vaccine, 
which represents a signiﬁ  cant contribution to Millennium 
Development Goal 4. Without the vaccine, more than 
10 million children would have died in the past decade 
from measles and its complications.5 
In 2011, the virus killed about 430 children every 
day.6 Since measles is so infectious and ﬁ nds pockets 
of unprotected populations, it can reveal gaps in public 
health provision. The root cause is almost always 
failure to vaccinate, but the reasons for this failure are 
illuminating. Some communities may lack access to 
basic immunisation but sometimes it is a question of 
conﬁ dence and often, where deaths from infectious 
disease have become less common, complacency has 
set in. Convenience is also a factor—for example, if 
immunisation is oﬀ ered only at times when both parents 
are working. In other countries there are perplexing, 
bureaucratic barriers to the purchase of vaccine. Where 
the vaccine does not reach communities because of 
conﬂ ict or emergency, or where routine immunisation 
quality is simply not high enough, the tragedy of 
measles continues. In the UK, the preparedness of the 
media to champion claims over the lack of safety of 
measles, mumps, and rubella (MMR) vaccination is now 
bearing fruit with the highest attack rates of measles in 
adolescents whose parents shunned MMR.7
To improve public health, countries should pay close 
atten tion to the epidemiology of measles outbreaks and 
take appropriate action. In the WHO European Region 
nearly 50% of measles cases occurred in adolescents and 
young adults between 2011 and 2012,3 a statistic clearly 
evident in recent outbreaks that can be directly linked to 
a lack of access to vaccines at some point in the past, or 
to the decisions parents took not to vaccinate their chil-
dren years ago. In Ethiopia adolescents are also getting 
measles, because basic vaccines were not available when 
they were younger. How do we now meet our measles 
commitments? First, we must take them very seriously. 
All Member States of the WHO European Region have 
com mitted to eliminating measles and rubella by 2015.8 
Furthermore, all WHO Member States adopted the 
Global Vaccine Action Plan, which includes commitment 
to the measles mortality reduction and elimination 
targets as goals. 
Second, we must invest more. Routine immunisation 
is the bedrock of any immunisation programme. As we 
introduce new vaccines, we must not forget to continue 
to invest in improving access to the old ones. To invest 
wisely, we must engage with the public to understand 
why some people choose not to vaccinate. It is too easy 
to blame parents for low vaccination coverage and we 
will achieve better results with more discussion.
Third, we must capitalise on existing opportunities. 
The WHO Regional Oﬃ  ce for Europe and partners 
stand ready to provide ﬁ nancial and technical support 
to Member States and to assist them in accelerating 
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action towards regional goals. The Measles and 
Rubella Initiative, which has helped deliver more than 
1·1 billion doses of measles vaccine in the past decade, 
has funding and expertise on oﬀ er. The GAVI Alliance 
is oﬀ ering ﬁ nancing for eligible countries to introduce 
measles-rubella vaccine and a measles second dose.
Measles campaigns remain a critical component of pub-
lic health. They must reach all susceptible populations as 
indicated by the epidemiology. Encouraged by reduc ing 
measles deaths by more than 70% globally since 2001,4 
countries and partners must also do their utmost to 
ensure campaigns are of the highest quality and close the 
immunity gap once and for all. The 2015 deadline is fast 
approaching and if we miss children today, they will get 
measles tomorrow. 
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Should the UK introduce compulsory vaccination?
Inevitably, an outbreak of a vaccine-preventable disease 
in the UK triggers calls for compulsory vaccination. 
As of April 17, 2013, 808 cases of measles have been 
reported in the Swansea area, about 10% of which have 
led to hospital admission.1 One young adult who died 
is known to have had measles at the time, but it has not 
yet been conﬁ rmed if he died because of measles. Large 
outbreaks of measles have also occurred in northern 
England, with 865 conﬁ rmed cases in northwest England.2 
Measles has a case fatality rate of between 1 per 1000 
and 1 per 3000 reported measles cases,3 and unless the 
outbreaks are brought to a halt, more deaths will result.  
The lack of compulsory childhood vaccination in the 
UK has been called into question: commentators look to 
the USA where there is an element of compulsion and 
ask why the UK does not go down that route.4 Although 
arguments for compulsory vaccination are superﬁ cially 
compelling, further examination suggests it is not so 
straightforward. In the USA, stronger enforcement of 
immunisation laws in a state before entry to public school 
are associated with higher vaccine coverage and lower 
incidence of some vaccine-preventable infections in those 
states.5 However, these comparisons fall down when 
com pari sons are made between countries. In 2011, the 
uptake of the ﬁ rst dose of measles, mumps, and rubella 
(MMR) vaccine among 2 year olds in the UK was similar to 
that in the USA (89·1% vs 89·7%).6,7 The Nordic countries 
successfully eliminated all three diseases8 without compul-
sory vaccination, while high vaccine uptake is achieved in 
other parts of Europe without compulsion.9 100 years of 
compulsory smallpox vaccination in the UK was a mixed 
blessing. Although some parents were persuaded to have 
their children immunised, the law turned others into 
martyrs and disproportionately aﬀ ected the poor for 
whom the ﬁ nes were a signiﬁ cant burden. Over the years, 
enforce ment of compulsory smallpox vaccination became 
less rigorous and more exemptions were granted.10
What impact might mandatory vaccination or penal-
ties for non-uptake have in the 21st century? Under-
immunised children comprise two main groups: those 
who are partially vaccinated because their parents have 
diﬃ  culties in accessing services or for other practical 
reasons, and those whose parents have decided to reject 
immunisation, often due to their perceptions of the 
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